JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$5.77B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$5.31B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.14B |
| 4 |
Meta Platforms (Facebook)
META
|
+$2.76B |
| 5 |
Apple
AAPL
|
+$2.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.22B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$1.77B |
| 3 |
Nike
NKE
|
+$744M |
| 4 |
Schwab US TIPS ETF
SCHP
|
+$710M |
| 5 |
Truist Financial
TFC
|
+$605M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 10.48% |
| 3 | Financials | 8.96% |
| 4 | Consumer Discretionary | 8.42% |
| 5 | Industrials | 7.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
Bank7 Corp
BSVN
$479M
| $105K | ﹤0.01% |
4,284
-4,880
| -53% | -$116K |
|
|
HUT
5202
Hut 8
HUT
$12.1B
| $105K | ﹤0.01% |
6,366
+880
| +16% | +$9.02K |
|
5203
HUTCHMED
HCM
$1.93B
| $104K | ﹤0.01% |
8,708
-8,791
| -50% | -$120K |
|
|
CVAC
5204
DELISTED
CureVac
CVAC
| $104K | ﹤0.01% |
+9,967
| New | +$89.1K |
|
|
VBNK
5205
VersaBank
VBNK
$623M
| $104K | ﹤0.01% |
13,700
-1,100
| -7% | -$7.96K |
|
5206
LiveWire
LVWR
$371M
| $104K | ﹤0.01% |
8,787
+8,542
| +3,487% | +$71K |
|
5207
NI Holdings
NODK
$310M
| $104K | ﹤0.01% |
6,983
+503
| +8% | +$6.85K |
|
|
DEN
5208
PUT
DELISTED
Denbury Inc.
DEN
| $104K | ﹤0.01% |
1,200
+800
| +200% | +$72.5K |
|
|
OPRA
5209
Opera Ltd
OPRA
$1.69B
| $103K | ﹤0.01% |
5,200
+200
| +4% | +$2.85K |
|
5210
Verrica Pharmaceuticals
VRCA
$89.7M
| $103K | ﹤0.01% |
1,787
+1,663
| +1,341% | +$101K |
|
5211
5E Advanced Materials
FEAM
$45.7M
| $103K | ﹤0.01% |
1,365
+59
| +5% | +$5.6K |
|
5212
First Trust Industrials/Producer Durables AlphaDEX Fund
FXR
$728M
| $103K | ﹤0.01% |
1,713
-56,310
| -97% | -$3.13M |
|
|
MACK
5213
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $103K | ﹤0.01% |
+8,344
| New | +$104K |
|
|
RBOT
5214
DELISTED
Vicarious Surgical
RBOT
| $102K | ﹤0.01% |
1,865
+450
| +32% | +$28.7K |
|
5215
CapForce IBD 50 ETF
FFTY
$79.5M
| $102K | ﹤0.01% |
4,000
+3,437
| +610% | +$81.4K |
|
|
GCMGW
5216
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
| – | – |
0
| – | – |
|
5217
First Community Corp
FCCO
$321M
| $102K | ﹤0.01% |
5,885
+5,849
| +16,247% | +$107K |
|
|
LLAP
5218
DELISTED
Terran Orbital Corporation
LLAP
| $102K | ﹤0.01% |
67,944
+36,406
| +115% | +$57.6K |
|
5219
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.19B
| $102K | ﹤0.01% |
604
| – | – |
|
5220
On Holding
ONON
$12.1B
| $102K | ﹤0.01% |
+3,085
| New | +$93.8K |
|
5221
CALL
Peabody Energy
BTU
$2.6B
| $102K | ﹤0.01% |
4,700
-600
| -11% | -$13.3K |
|
|
IVAC
5222
DELISTED
Intevac Inc
IVAC
| $102K | ﹤0.01% |
27,113
+20,938
| +339% | +$112K |
|
5223
USCB Financial Holdings
USCB
$406M
| $101K | ﹤0.01% |
9,927
+1,669
| +20% | +$16.4K |
|
|
EIGR
5224
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $101K | ﹤0.01% |
4,792
-2,897
| -38% | -$89.2K |
|
|
PSTX
5225
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $101K | ﹤0.01% |
57,435
+55,686
| +3,184% | +$142K |
|
Similar funds
JP Morgan Chase's Q2 2023 Portfolio in Review
As of Q2 2023, JP Morgan Chase held 7,602 positions worth $920B, up 12% from $821B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
JP Morgan Chase deployed $40.5B of net new capital in Q2 2023, opening 674 new positions and adding to 3,069 existing holdings. Its largest new stake was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares 0-1 Year Treasury Bond ETF, an estimated $3.22B trimmed.
- JP Morgan Chase's largest Q2 2023 buy was JPMorgan BetaBuilders Emerging Markets Equity ETF: 10,009,525 shares worth $488M.
- JP Morgan Chase added most to Microsoft in Q2 2023, an estimated $5.77B increase.
- JP Morgan Chase's biggest Q2 2023 reduction was iShares 0-1 Year Treasury Bond ETF, cutting an estimated $3.22B.
- JP Morgan Chase fully exited DCP Midstream, LP in Q2 2023, selling an estimated $328M.
- JP Morgan Chase's ten largest holdings make up 20% of its $920B portfolio in Q2 2023.
- JP Morgan Chase opened 674 new positions and closed 737 in Q2 2023.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $920B.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.